Bendamustine and Erlotinib in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Breast Cancer
Clinical trial NCT00834678 · COMPLETED
Trial details
- NCT number
- NCT00834678
- Sponsor
- Ohio State University Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-01
- Primary completion
- 2013-08-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.